Scientists explore fetal gene editing to treat rare genetic disorders
Researchers are investigating the use of CRISPR technology to edit genes in fetuses before birth.
At a glance
- Researchers are exploring fetal gene editing to treat rare genetic disorders
- The approach aims to intervene before genetic conditions cause lasting damage
- Scientists are investigating CRISPR technology for this purpose
Researchers are exploring the use of fetal gene editing as a potential treatment for rare genetic disorders. The approach aims to address genetic conditions before they cause lasting damage to the developing fetus.
Scientists are investigating whether CRISPR technology could be used to treat these conditions during pregnancy, potentially preventing symptoms from developing after birth.
Why it matters
Gene editing technology could offer new treatment options for rare genetic diseases that currently have limited therapeutic approaches.
Original reporting
This brief was written with AI assistance from the reports listed above and checked against our editorial policy. Spotted an error? Request a correction.
